Product Information

HYDROMORPHONE 4 MG TABLET is a generic product labeled by Rhodes Pharmaceuticals L.P., priced at $0.2260 per EA under NDC 42858030225. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Dec 7, 1992. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

HYDROMORPHONE 4 MG TABLET

Hydromorphone Hydrochloride
$0.2260per EA
DEA Schedule CII

Strength

4 mg/1

NDC

42858030225

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

HYDROMORPHONE HYDROCHLORIDE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA019892

FDA Approved

12/7/1992

TE Code

AB

On Market Since

11/23/2009

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price Statistics

The NADAC for HYDROMORPHONE 4 MG TABLET has been published 678 times since Nov 28, 2013, and over the history we have for it it has risen 119.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2260 per EA
All-time high$0.2260 (Nov 18, 2026)
All-time low$0.0822 (Apr 17, 2019)
52-week high$0.2260
52-week low$0.1909
Median price$0.0964
Average price$0.1138
Largest weekly change+52.1% (Aug 21, 2024)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

+2.6%

1M

+3.1%

3M

+4.3%

6M

+3.8%

1Y

+17.9%

3Y

+81.4%

5Y

+149.2%

All

+119.3%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of HYDROMORPHONE 4 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for HYDROMORPHONE 4 MG TABLET, manufactured by Rhodes Pharmaceuticals L.P., is $0.2260 per EA (NDC 42858030225), effective Nov 18, 2026.

How has the price of HYDROMORPHONE 4 MG TABLET changed over time?

Over the history we have for it, the NADAC for HYDROMORPHONE 4 MG TABLET has risen 119.3%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for HYDROMORPHONE 4 MG TABLET?

Since Nov 28, 2013, the NADAC for HYDROMORPHONE 4 MG TABLET has ranged from a low of $0.0822 (Apr 17, 2019) to a high of $0.2260 (Nov 18, 2026), with a median of $0.0964 per EA.

Are there cheaper alternatives to HYDROMORPHONE 4 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as HYDROMORPHONE 4 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures HYDROMORPHONE 4 MG TABLET?

HYDROMORPHONE 4 MG TABLET (NDC 42858030225) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a generic product.